This is what is in CerAxon that Diane from Pink House on the Corner thought helped Bob.
I've written 3 posts on this, you'll have to see what your doctor thinks of this.
http://www.financialexpress.com/article/pharma/latest-updates/drl-launches-somazina-for-stroke-patients-in-india/72814/
Dr Reddy’s Laboratories (DRL) has launched Somazina, the innovator
brand of Citicoline in the Indian market. DRL has partnered with the
global innovator of Citicoline, Ferrer Internacional, Spain, to make
Somazina available in India. This product has been used for the
treatment of post-stroke patients around the world.
Somazina is indicated for improving cognitive function in patients
who have suffered from stroke or cerebral infarction, or who have
undergone a brain surgery or have suffered from head injuries.
Citicoline is a widely used neuro-protectant to help accelerate the
recovery of these patients. It is used in both ischemic and haemorrhagic
strokes, and provides a compelling option to physicians treating stroke
patients.
No comments:
Post a Comment